[11C]UCB-J PET brain scans in 34 patients with early stage AD detected significant, volume loss-adjusted reductions in SV2A binding in medial temporal and neocortical regions, compared to brain scans of 19 cognitively normal controls. The gene discussed is SV2A; the disease is Alzheimer disease.